A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.

NCT07161687 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A or B

Interventions

DRUG: Marstacimab

Sponsor

Pfizer